Wanyi Pan

Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies

Xiaopeng Peng, Zhihao Hu, Limei Zeng et al. · Acta Pharmaceutica Sinica B · 2023 · 68 citations · Full text

Medicine, Oncology, Pharmacology +14

Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects

Xiaopeng Peng, Yichang Ren, Wanyi Pan et al. · Journal of Medicinal Chemistry · 2022 · 20 citations · Full text

Medicine, Medicinal Chemistry, Oncology +15

RETRACTED ARTICLE: Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma

Xiaopeng Peng, Ziwen Yu, Goverdhan Surineni et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy

Zhihao Hu, Shuqing Li, Haiqi He et al. · Journal of Medicinal Chemistry · 2025 · 12 citations

Medicine, Oncology, Pharmacology +17